Global Insulin Pump Market

Insulin Pump Market Size, Share, Growth Analysis, By Type(Patch pumps, and Tethered pumps), By Product(MiniMed, Accu-Chek, Tandem, Omnipod), By Accessories(Insulin Eeservoir or Cartridges, Insulin Set Insertion Devices, and Battery), By End Use(Hospitals & Clinics, Homecare, and Laboratories), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2135 | Region: Global | Published Date: September, 2024
Pages: 165 | Tables: 88 | Figures: 76

Insulin Pump Market Regional Insights

The global market for insulin pumps includes recent trends and potential prospects for each region, including Europe, North America, Asia Pacific (APAC), the Middle East, and Africa (MEA). Due to the increased prevalence of diabetes, North America will dominate the market for these throughout the projection period. In addition, the presence of major industry players in the area, the rising obesity rate, the accessibility of cutting-edge medical facilities, the high consumption of fast food, technological advancements, and consumers' sedentary lifestyles all contribute to market growth. The region's major contributors are the United States and Canada.

Europe is expected to hold the second-largest share of the worldwide insulin pump market during the projected period due to the presence of numerous key market players there, the availability of cutting-edge medical facilities, and technological advances. The region's national markets include the UK, Spain, Italy, Germany, and France.

Over the course of the forecasted period, it is expected that the APAC region would witness rapid growth in the worldwide insulin pump market. Growing health consciousness, the availability of cutting-edge medical facilities, an increase in disposable income, better medical facilities in South Korea, Japan, Australia, India, and China, and an increase in the prevalence of diabetes in Taiwan, Malaysia, Indonesia, India, and China are some of the factors driving the market growth in the region. Due to their underdeveloped economies, strong government regulations, lack of awareness, restricted access to technology, and reduced focus on healthcare improvement, the MEA will only account for a minor portion of the global insulin pump market over the projection period.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Insulin Pump Market size was valued at USD 5.59 billion in 2022 and is poised to grow from USD 6.05 billion in 2023 to USD 11.38 billion by 2031, growing at a CAGR of 8.22 % in the forecast period (2024-2031).

The Global Insulin Pump Market is fairly concentrated, with a few big and medium-sized market participants accounting for a large portion of market revenue. A small number of significant businesses control a sizable portion of the market, which is consolidated. With a broad selection of pumps and supplies for the treatment of diabetes, market leader Medtronic maintains a commanding position. The growth of the business is also supported by the regulatory bodies' rising product approvals. Major players are including China National Petroleum Corporation, Exxon Mobil Corporation, Sasol, and Evonik Industries. 'Medtronic (Ireland) ', ' ', ' ', ' ', 'Hoffmann-La Roche AG (Switzerland) ', 'Tandem Diabetes Care, Inc. (US) ', 'Insulet Corporation (US) ', 'Ypsomed AG (Switzerland) ', 'Sanofi S.A. (France) ', 'Sooil Development (Korea) ', 'Jiangsu Delfu Co., Ltd. (China) ', 'Cellnovo Ltd. (UK) ', 'Valeritas, Inc. (US) ', 'Debiotech S.A. (Switzerland) ', 'CeQur Simplicity (Switzerland) ', 'Microtec Medical Ltd. (UK) ', 'ViCentra B.V. (Netherlands) ', 'EOFLOW CO., LTD. (Korea) ', 'Becton, Dickinson and Company (US) ', 'Abbott Laboratories (US) ', 'Braun Melsungen AG (Germany) ', 'Animus Corporation (US) ', 'Asante (US) ', 'Nipro Diagnostic, Inc. (Japan)'

The market participants are concentrating on R&D of technologically advanced goods and launching new products in response to the growing adoption of these pumps among diabetic patients in developed and emerging nations. Several clinical trials that indicate indications of persistent improvement in glucose control in type 2 diabetes patients receiving pump therapy as opposed to those receiving Multiple Daily Injection (MDI) therapy have complemented R&D.

Intelligent technologies, including AI, have quickly impacted the healthcare IT sector and are currently making steady progress in the management of diabetes. Medical device businesses can actively develop and introduce AI-enabled pumps and other automated drug delivery systems for type 2 diabetes by leading the way in these trends. There is a demand for technologically sophisticated pumps due to the type 2 diabetes population's growing use of these pumps. For instance, according to Medtechdive, the global adoption rate of type 2 insulin pumps is now about 5%, with an expected 15% growth by 2027.

The global market for insulin pumps includes recent trends and potential prospects for each region, including Europe, North America, Asia Pacific (APAC), the Middle East, and Africa (MEA). Due to the increased prevalence of diabetes, North America will dominate the market for these throughout the projection period. In addition, the presence of major industry players in the area, the rising obesity rate, the accessibility of cutting-edge medical facilities, the high consumption of fast food, technological advancements, and consumers' sedentary lifestyles all contribute to market growth. The region's major contributors are the United States and Canada.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Insulin Pump Market

Report ID: SQMIG35A2135

$5,300
BUY NOW GET FREE SAMPLE